Using this system, we confirmed that VEGF inhibitor specifically hindered the angiogenesis of lung cancer, suggesting that this system has potential applicability in the discovery of new selective angiogenesis inhibitors as a quantitative assay to test candidate compounds. This evidence concerns the gene VEGFA and lung carcinoma.